📋 Several Taiwanese stocks are positioned as CPO exposure longs, with potential for growth as photonics scaling and industry events unfold

medium convictionFirst mentioned May 26, 2026

Several Taiwanese stocks are positioned as CPO exposure longs, with potential for growth as photonics scaling and industry events unfold.

Evidence & details
Evidence
  • +FOCI is the bottleneck for CPO volume ramp
  • +FOCI is main supplier for TSM and NVDA
  • +POET has higher valuation despite FOCI's strategic position
Catalysts
  • Institutional discovery
  • Potential NASDAQ ADR listing
Risks
  • Valuation disparity may persist
  • Liquidity or listing issues

Chart

Post Timeline · 3 posts

new thesishigh

HOW DOES $POET ($3.14B) HAVE A HIGHER VALUATION THAN FOCI (3363, $3.1B)??? FOCI IS LITERALLY THE BOTTLENECK FOR CPO VOLUME RAMP AND MAIN SUPPLIER FOR $TSM AND $NVDA. High conviction Foci outperforms once institutions find this name. Also, can Foci management please pursue NAS…

Thesis: Post argues that FOCI is undervalued compared to POET, highlighting FOCI's critical role as bottleneck for CPO volume ramp and main supplier to TSM and NVDA, expecting outperformance once institutions…

view on X ↗POET · FOCI
new thesishigh

Honestly I’m expecting FOCI (3363) to blow away projections over next two years. It’s a pretty high conviction position for me medium term at this level. Since they’re expected to be the leading supplier to $NVDA and $TSM and get frequently cited as a bottleneck for that $91B+…

Thesis: FOCI is expected to be a leading supplier to NVDA and TSM, acting as a critical bottleneck for the CPO TAM, and is undervalued compared to peers.

new thesishigh

People wonder why I'm focusing on non-US markets recently. Why? CPO is my #1 thematic long. Markets don't know yet, the sudden paradigm shift in photonics... I was one of the only to frontrun the current supercycle in 2025 w/ $AAOI @ ~$30, $LITE ~$300s, and $AXTI at ~$13 on…

Thesis: CPO (co-packaged optics) is the #1 thematic long with TAM going from $0 to $91B. New dominant players in non-US markets (Europe: SIVE, SOI) and existing US players (LITE, COHR) stand to benefit. Legac…

view on X ↗SIVE · SOI · LITE · COHR
Current Price
$797.00
via cornerstones
Return from entry
entry May 26, 2026
Thesis Lifecycle
👀
watchedMay 26, 2026

Several Taiwanese stocks are positioned as CPO exposure longs, with potential for growth as photonics scaling and industry events unfold.

source ↗